Brain Myelination Effects of Paliperidone Palmitate vs. Oral Risperidone in First Episode Schizophrenia.

Trial Profile

Brain Myelination Effects of Paliperidone Palmitate vs. Oral Risperidone in First Episode Schizophrenia.

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 15 Jun 2012

At a glance

  • Drugs Paliperidone; Risperidone
  • Indications Schizophrenia
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 15 Jun 2012 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov.
    • 15 Jun 2012 Planned initiation date changed from 1 Oct 2011 to 1 Aug 2012 as reported by ClinicalTrials.gov.
    • 26 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top